Strata Critical Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | — |
| Gross profit | $41.1M | $29.6M | — | — | — |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | — |
| Operating expenses | $63.5M | $52.1M | $33.2M | $36.6M | — |
| Cost of revenue | $156.0M | $117.2M | $183.1M | $123.8M | — |
| Cash from operations | -$48.9M | -$2.5M | -$32.3M | -$37.1M | — |
| Capital expenditure | $9.6M | $30.9M | $2.1M | $730,000 | — |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | — |
| Share repurchases | $0 | $244,000 | $0 | — | — |
| Impairments | $0 | $5.8M | $20.8M | — | — |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $335.9M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $44.5M |
Shares outstanding 86.5M · Free float 68.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.